Cingulate Therapeutics
Bryan Lawrence, PharmD, MBA, is an experienced leader in the pharmaceutical and healthcare consulting industries. Currently serving as a member of the Board of Directors at Cingulate Inc. since February 2024, Lawrence has held significant roles throughout his career, including Vice President of Corporate Development at AmerisourceBergen and Partner/Corporate Development Officer at Xcenda. Lawrence's background includes driving growth and strategy in various organizations, such as Applied Health Outcomes, Navigant Consulting, Johnson & Johnson, and Janssen Pharmaceutica, with a focus on managed care marketing, outcomes research, and corporate account management. Educational credentials include an MBA from The Wharton School, a Research Fellowship in Pharmacoeconomics from the University of South Carolina, and a Doctor of Pharmacy from The University of Kansas.
This person is not in any teams
This person is not in any offices
Cingulate Therapeutics
1 followers
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.